Trial Profile
Single-blind randomised controlled phase 1b trial of the safety and immunogenicity of lyophilised recombinant precipitated tropical malaria vaccine (BK-SE36) in Uganda.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs NPC 19 (Primary)
- Indications Malaria
- Focus Adverse reactions
- 21 Apr 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 30 Jul 2009 Planned end date changed from 21 Nov 2009 to 21 Apr 2010 as reported by ISRCTN: Current Controlled Trials. record.
- 30 Jul 2009 Planned initiation date changed from 23 Apr 2009 to 22 Sep 2009 as reported by ISRCTN: Current Controlled Trials. record.